2Gregersen H, Ibsen JS, Nielsen M. Renal insufficiency in myelomatosis. Prognostic factors and survival. Ugeskr Laeger,1997 ,159:3387-3392.
3Irish AB, Winearls CG, Littlewood T. Presentation and survival of patients with severe renal failure and myeloma. QJM, 1997,90:773-780.
4Pierre MR. Monoclonal gammopathies: multiple myloma, amyloidosis and related disorders. In: Robert WS, Carl WG, eds. Disease of the kidney. 6th ed. New York : Little, 1996.2130-2145.
5Kapadia SB. Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore), 1980,59:380-392.
6Blade J, Fernandez-Llama P, Bosch F, et al.Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution.Arch Intern Med,1998 ,158:1889-1893.
3Pieken MM. New insights into systemic amyloidosis- the importance of diagnosis of specific type [ J J. Curr Opin Nephrol Hypertens, 2007,16(3) :196 -203.
5Verani RR. Fibrillary glomerulopathy [J]. Kidney: a current survey of world literature, 1993,2:63 - 66.
6Randall RE, Williamson WC Jr, Mullinax F, et al. Manifestations of systemic light chain deposition [ J ]. Am J Med, 1976,60 (2) : 293 - 299.
7Kyle RA,Rajkumar SV.Monoclonal gammopathies of undetermined Significance:a review[J].Immunological Reviews,2003,194:112-139.
8Kyle RA,Therneau TM,Rajkumar SV,et al.A long-term study of prognosis in monoclonal gammopathy of undetermined significance[J].N Engl J Med,2002,346:564-569.
